Evidence map›Paper›PMID 32719133›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Objecting to experiments even while approving of the policies or treatments they compare.

Patrick R Heck, Christopher F Chabris, Duncan J Watts, Michelle N Meyer

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Experiment aversion does generalize, but it can also be mitigated.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  4. Reply to Vogt et al.: What does it mean that a phenomenon generalizes?Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  5. Reply to Bas et al.: The difference between a genuine tendency and a context-specific response.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  6. No evidence that experiment aversion is not a robust empirical phenomenon.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  7. Experiment aversion does not appear to generalize.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  8. Objecting to experiments even while approving of the policies or treatments they compare.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Patrick R HeckCenter for Translational Bioethics and Health Care Policy, Geisinger Health System, Danville, PA 17822; pheck1000@gmail.com.ORCID 0000-0003-0819-3890
Christopher F ChabrisAutism and Developmental Medicine Institute, Geisinger Health System, Lewisburg, PA 17837.ORCID 0000-0002-7379-7378
Duncan J WattsAnnenberg School for Communication, University of Pennsylvania, Philadelphia, PA 19104.ORCID 0000-0001-5005-4961
Michelle N MeyerCenter for Translational Bioethics and Health Care Policy, Geisinger Health System, Danville, PA 17822.ORCID 0000-0001-5497-8803

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We resolve a controversy over two competing hypotheses about why people object to randomized experiments: 1) People unsurprisingly object to experiments only when they object to a policy or treatment the experiment contains, or 2) people can paradoxically object to experiments even when they approve of implementing either condition for everyone. Using multiple measures of preference and test criteria in five preregistered within-subjects studies with 1,955 participants, we find that people often disapprove of experiments involving randomization despite approving of the policies or treatments to be tested.

Indexed as

Ethics, ResearchHumansRandom AllocationRandomized Controlled Trials as TopicResearchA/B testsfield experimentspragmatic trialsrandomized controlled trialsresearch ethics

Identifiers

PMID32719133
PMCPMC7430984

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.